Endo International Profile

USD 0.08  1.18%

Exercise of in-the-money or at-the-money derivative position by Kelso Partners V L P of 4646 shares of Endo International

Endo International plc insider trading alert for exercise of common stock par value $.01 per share by Kelso Partners V L P, the corporate stakeholder, on February 21, 2018. This event was filed by Endo International Plc with SEC on 2005-12-05. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

Endo International Summary

Endo International plc (ENDP) is traded on NASDAQ in USA. It is located in IRELAND and employs 4,894 people. Endo International is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Mid-Cap' category with current market capitalization of 1.54 B. Endo International plc conducts business under Healthcare sector and is part of Drug Manufacturers - Other industry. This company has 223.31 M outstanding shares of which 697.3 K shares are currently shorted by private and institutional investors with about 50.08 trading days to cover. ENDO PHARM HLDGS currently holds about 738.39 M in cash with 505.12 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.31.
Check Endo International Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Tpg Group Holdings Sbs Advisors IncCommon Shares22.2 M171.7 M
Blackrock IncCommon Shares21.4 M166 M
View Endo International Diagnostics

Selected Endo International plc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Endo International Against Markets

Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
< 52% 
Equity ratings for Endo International plc are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Endo International plc develops, manufactures, and distributes pharmaceutical products and devices worldwide. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland. Endo International operates under Drug Manufacturers - Other classification in USA and traded on NASDAQ exchange. It employs 4894 people. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameEndo International plc
President CEO, DirectorPaul CampanelliAll Leadership
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Bond Rating
Healthcare, Pharmaceuticals And Biosciences
InstrumentUSA Stock Stocks Directory
Business AddressMinerva House
IndustryDrug Manufacturers - Other
Contact Number353 1 268 2000
CurrencyUSD - US Dollar

Did you try this?

Run Equity Forecasting Now

Equity Forecasting

Use basic forecasting models to generate price predictions and determine price momentum
Hide  View All  NextLaunch Equity Forecasting


Endo International Analyst Recommendations
Target PriceAdvice# of Analysts
Endo International plc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Endo International Analyst Advice  


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  


Endo International Earnings Estimates
EPSEstimate Date
Quarterly Estimate1.63February 28, 2017
Endo International plc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate  


Endo International Corporate Directors
William Spengler Director
Arthur Higgins Independent Director
William Montague Director